Literature DB >> 6387556

Intensified conventional insulin therapy for the pregnant diabetic patient.

P A Weiss, H Hofmann.   

Abstract

Thirty-three normoglycemic pregnant diabetic patients (White B-R) were studied in the course of one year during 732 weeks of therapy with 176 dose adjustments of insulin to determine patterns of insulin requirements. By means of an empirical formula, the insulin requirements within a 24-hour period can be calculated. Insulin requirement in the course of pregnancy decreases significantly between the tenth and the 16th week of gestation (-12%, P = less than .001). From the 17th to the 36th week it increases slightly at first and more markedly from the 28th week onward (+ 62%), decreasing again from the 36th week onward. Insulin distribution during the day depends on whether or not a residual function of beta cells and, consequently, basal insulin secretion exists. Either four doses of regular insulin are injected or three doses of regular insulin are combined with one to two doses of variously long-acting insulin. The ideal distribution regarding the type and amount of insulin follows certain patterns and can therefore be approximated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6387556

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Type 1 diabetes mellitus and pregnancy.

Authors:  Roberto Vargas; John T Repke; Serdar H Ural
Journal:  Rev Obstet Gynecol       Date:  2010

2.  Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial.

Authors:  Z Nachum; I Ben-Shlomo; E Weiner; E Shalev
Journal:  BMJ       Date:  1999-11-06

3.  Insulin binding to trophoblast plasma membranes and placental glycogen content in well-controlled gestational diabetic women treated with diet or insulin, in well-controlled overt diabetic patients and in healthy control subjects.

Authors:  G Desoye; H H Hofmann; P A Weiss
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

4.  Continuous insulin delivery systems for the pregnant diabetic patient.

Authors:  H M Hofmann; P A Weiss; J G Haas
Journal:  Acta Diabetol Lat       Date:  1986 Jul-Sep

5.  Molecular phenotyping of immune cells from young NOD mice reveals abnormal metabolic pathways in the early induction phase of autoimmune diabetes.

Authors:  Jian Wu; Dorothy N Kakoola; Nataliya I Lenchik; Dominic M Desiderio; Dana R Marshall; Ivan C Gerling
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.